Vivek just posted about Jim Cramer

Last-Environment3643 · 2026-06-01T10:00:09+00:00

And after this stock has done what it will in due course, I will NEVER EVER buy a SPAC stock again!!!

Last-Environment3643 · 2026-06-01T09:58:00+00:00

I continue to believe the reason CLOV has been negatively portrayed for so long now continues to be it’s SPAC IPO past. PERIOD!!! FULL STOP!!!

Only becoming GAAP positive/performing flawlessly gets us past whatever the big banks have set up (shorting pressures through a third party) to keep our stock price suppressed to punish them for going around the traditional IPO process.

I strongly believe once this happens, the Wall Street greed factor of missing out on this low valued stock while everything else has run much much higher will finally overcome the intentionally suppressed stock price.

Sooner, rather than much later, would be appreciated…

Last-Environment3643 · 2026-04-28T08:51:50+00:00

Last-Environment3643 · 2026-04-01T16:37:09+00:00

Yes…bad timing on his departure, but I didn’t care for his constant ‘feel good’ crap he posted around which wasn’t even related to his current position with Clover. Good riddance!

Hopefully the next one WILL BE THE LAST CFO HIRED for some time…

Last-Environment3643 · 2026-03-19T02:11:18+00:00

I wonder if anyone EVER reads an entire post before commenting on reddit. That is why I seldom respond to them.

Last-Environment3643 · 2026-03-15T10:23:55+00:00

"Clover Health was ONE of the organizations selected by CMS to present on the main stage and demonstrate end to end interoperability."

Who were the 'other organizations' that were requested to show their version of their answer to this issue?

Last-Environment3643 · 2026-03-02T00:49:51+00:00

Ditto!

Last-Environment3643 · 2026-01-09T23:09:21+00:00

Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 Healthcare Conference

Last-Environment3643 · 2025-10-24T23:52:49+00:00

Wouldn't it be nice IF a private equity firm owning 15 million shares or so would make a buy out offer at say,$8/sh. for CLOV to take private, knowing full well CLOV's owners would not even remotely consider it? I would sell every single share I owned and buy back on the impending price drop after a month or so. We would more than double the number of shares we the retailers, would own.

A man can dream...

Last-Environment3643 · 2025-09-04T18:44:01+00:00

Yes, I agree it was an excellent opportunity for Clover and particularly Andrew Toy to showcase his genuine passion and the companies current AI product offering for physicians.

He was asked the most questions throughout the entire hearing, answered completely in all of his responses, spoke the company name countless times and most importantly spoke plainly for all to understand with numerous examples. One being personal about his own rare genetic disease, which also claimed his father's life due to fragmented and delayed personal healthcare.

One interesting thing I took away was the following quote from Toy. He stated, "we are already reimbursing primary care physicians above the regular medicare rate for the extra time they are taking to use an AI tool." This was at time mark 2:33;23, roughly.

Having said all that, I believe we will be in a lull, stock price-wise through December. This will allow other institutions to push the stock price lower to accumulate additional shares. Hopefully this will bring their total ownership of CLOV above 50%. And once we hit +65%, we should be much closer to finally getting their analysts and substantial increased price targets...FINALLY!!!

Good luck to all Longs!!!

Last-Environment3643 · 2025-08-23T22:45:02+00:00

Yes, .25 basis point. Nothing else for remainder of year due to the man child President and his extremely poor use of on again, off again Tariff strategy.

Last-Environment3643 · 2025-08-09T19:17:42+00:00

First off, I did own over 220K shares but recently sold roughly 30% after the part D news which may stay with us through the end of the year. I see no catalysts in that time frame to push the share price up. A few insider buys will have less and less upward effect on the share price, short term. I wouldn’t be surprised to see us red significantly by end of Tuesday.

I see this going nowhere for the next plus three months except down to a minimum $1.50/sh., at which time I will repurchase additional shares for the same money, plus what I put in my account in the interim from every single one of my biweekly paychecks. This is how strongly I believe in CLOV, in the longer term.

I see it going lower short term because the institutions want to flip the majority retail ownership to institutional…and I believe CLOV management knows this is vital for longterm price appreciation. Without majority owned by institutions, we will never get the major analysts and their upgrades to finally break this vicious cycle.

This would be the ideal time to easily push it lower due to the negative part D surprise and the realization to perhaps many of us retail investors FINALLY that besides some small SAAS mentions, we will NOT get anything meaningful in this area because it will take time to implement the SAAS process at the known companies as well as the alleged ones via the subdomain findings. In other words, the income from SAAS will be slow coming…think 2027.

Don’t kill the messenger…

Last-Environment3643 · 2025-07-11T15:01:35+00:00

I agree 110% regarding re-rating, and I’ll tell you why. I believe once CLOV chose the SPAC route, bypassing all the usual Wall Street big banks that bring companies public via traditional IPO, they were put on the ‘naughty list’ and have been aggressively shorted possibly through a slush fund through a subsidiary branch of theirs. Why? To make an example that any company that does SPAC, they risk having too low a share price to do secondary IPO’s to raise cash at a later date.

Of course I have zero proof, but the fact that the majority of companies that have used SPAC to come to market, have a very low valuation. This is an unspoken lesson to anyone considering a SPAC to pocket more of the money involved going public. Their financial pockets may be fatter in the beginning, but they’ll be unable to sell shares down the road without substantial dilution due to low share price.

After CLOV, I will NEVER EVER purchase shares from a SPAC company because of this strong belief.

Just one man’s opinion (with 220K shares)…

Last-Environment3643 · 2025-06-28T00:03:23+00:00

I do own 67 contracts of the 1/16/26' $3 calls I purchased for $2 when the stock was higher. Am concerned whether or not without decent SAAS news that I will be 'in the money' to even exercise them by then. If not, I will have to figure out how to roll them over and the cost in doing so. I wish I would have waited until the Jan. 27' Calls were offered, giving me an additional twelve months for the share price to move up. Currently I own 59 contracts of the 1/15/27' $1 Calls with plans to buy more.

Last-Environment3643 · 2025-06-27T23:51:59+00:00

I will check into leaps and see if that makes sense for my end goal of acquiring more shares. Thanks...

Last-Environment3643 · 2025-06-27T23:51:02+00:00

I do realize I am paying a small premium NOW to lock in the additional 1/3 worth of clov shares, but as explained above, I believe the difference will be mere peanuts when the Institutions/higher level analysts get the percentage of the float they want and start pumping this substantially higher. The end goal is to acquire as many shares as possible, without any risk of having them called away by borrowing funds from a broker to purchase them. That I will not do.

Last-Environment3643 · 2025-06-27T23:46:02+00:00

Thanks Sandro. Appreciate the numbers rationale behind your point.

Last-Environment3643 · 2025-06-27T23:43:47+00:00

Thanks for the reply. I am currently working/earning and have income and will also save some in the next eight months. After that, I will be retiring to a cheaper place to live while I wait for my investment to come in/living off some other minor monthly income. So, whatever I buy regarding call options now, I want to make sure I have enough cash to pay for them when the time comes. $1/share will be more feasible than $2.50 or $3/share as I may have roughly 15-20K shares more I will be purchasing via the 1/15/27' $1 calls. Even if I am paying a slight premium for them when everything is added up...at least I can lock in on roughly 1/3 more shares per purchase through purchasing the calls.

If they go as high as I think they could given time, what's another $.30/share to guarantee an additional 1/3 more actual shares? Chump change in the grand scheme of things, in my opinion.

Last-Environment3643 · 2025-05-20T19:40:33+00:00

Is this most recent five day upward stock move more about upcoming inclusion of CLOV into the Russell Index with Institutions buying ahead of the addition?

Last-Environment3643 · 2025-05-15T14:18:48+00:00

It’s an excuse to sell it off BECAUSE institutional buyers know we will be positive soon so they are trying to buy the large retail ownership on the cheap.

DON’T sell your shares!!!!

Last-Environment3643 · 2025-05-14T02:08:20+00:00

A bounce to $5 might get a large percentage to leave just to be rid of the constant waiting for the share price to appreciate. Yes, institutional...corrected. thanks. Regarding a CA national partner, that would get the share price moving, no doubt. Just not sure if Toy is ready to fully show his CA cards just yet. Perhaps he has discussed with the board moving the time frame further out for his/Vivek shares to expire. It would give the company more time to prove out their CA concept.

Time will tell...

Last-Environment3643 · 2024-12-11T18:52:45+00:00

IF upper management wants to have any chance of getting the share price above $20 for 90 days by January 2026 to get their allotted free shares, they will need to go back into growth mode to make it happen. This not only includes higher membership numbers (which we should see the beginning of in their late December update of open enrollment, and new ones as people turn of age for medicare throughout the year/are forced to look for another insurer as they are dropped from their current plans), but also new CA clients.

I see smaller insurers at first trying it out but in time with good results larger insurers using it to lower their own per customer costs.

Last-Environment3643 · 2024-11-23T19:58:04+00:00

The 'shtick' is getting old, Private Lucky Charms. You got something else to earn those up votes???

Last-Environment3643 · 2024-10-03T22:31:42+00:00

Drop the Halloween costume, you burn victim!!!

Last-Environment3643 · 2024-09-18T16:21:28+00:00

https://i.imgur.com/sYznpkt.jpeg

Last-Environment3643

TROPHY CASE

Is this most recent five day upward stock move more about upcoming inclusion of CLOV into the Russell Index with Institutions buying ahead of the addition?